LLY: Eli Lilly and Company Stock

by  •  • Comments Off on LLY: Eli Lilly and Company Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 796,408.59
Enterprise Value ($M) 822,286.19
Book Value ($M) 13,635.50
Book Value / Share 15.14
Price / Book 58.41
NCAV ($M) -28,035.00
NCAV / Share -31.14
Price / NCAV -28.41

Profitability (mra)
Return on Invested Capital (ROIC) 0.17
Return on Assets (ROA) 0.13
Return on Equity (ROE) 0.65

Liquidity (mrq)
Quick Ratio 0.87
Current Ratio 1.11

Balance Sheet (mrq) ($M)
Current Assets 30,204.30
Assets 71,874.80
Liabilities 58,239.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 7.54 -2.49
02-09 13G/A Pnc Financial Services Group, Inc. 5.43 -0.56
01-29 13G/A BlackRock Inc. 6.80 -1.67
01-26 13G/A Lilly Endowment Inc 10.51 -3.09

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-21 10-K United States Securities and Exchange Commission Washington, D.C. 20549 Form 10-K Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023 Commission file number 001-06351 ELI LI
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2023 COMMISSION FILE NUMBER 001-635

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-02 193,532 1,368,538 14.14
2024-10-01 308,636 1,923,469 16.05
2024-09-30 270,320 2,287,904 11.82
2024-09-27 524,656 3,722,386 14.09

(click for more detail)

Similar Companies
ELAN – Elanco Animal Health Incorporated HYAC – Haymaker Acquisition Corp. 4
JNJ – Johnson & Johnson MRK – Merck & Co., Inc.
NUVB – Nuvation Bio Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Eli Lilly and Company